Medtronic plc

06/04/2026 | Press release | Distributed by Public on 06/04/2026 07:20

Medtronic expands its Acute Care & Monitoring wearables portfolio in the U.S. with a new distribution agreement for the Corsano™* multi-parameter wearable

Medtronic, a global leader in healthcare technology, has announced the expansion of its strategic partnership with Corsano Health B.V., a pioneering MedTech company specializing in advanced real-time remote patient monitoring solutions. Medtronic will exclusively distribute Corsano Health's cutting-edge wearable solution in the U.S. for hospital and hospital-to-home use, adding a wrist worn form factor to its remote patient monitoring portfolio. Additional terms of the agreement were not disclosed.

The multi-parameter wearable solution by Corsano Health is a medical grade, multi-parameter wearable designed for continuous monitoring of vital signs.1 The wearable captures metrics such as heart rate, intermittent respiratory rate, oxygen saturation (SpO2), skin temperature, and activity1, providing clinicians with seamless, real-time data and the ability to non-invasively monitor patients anytime, anywhere.1

Following its 2025 launch in Western Europe, the U.S. distribution agreement with Corsano Health expands the Acute Care & Monitoring portfolio of innovative solutions that are transforming digital health - connecting smart devices across the hospital ecosystem to drive insights.

"The Corsano™* multi-parameter wearable meaningfully expands our U.S. portfolio of wearable patient monitoring solutions, helping to protect more patients in more settings. Designed around direct health system feedback, the Corsano™* wearable is a future-ready solution for hospitals seeking to modernize care by maximizing their monitoring functionality.1 Connected through a flexible and scalable monitoring platform in a patient-friendly form factor, it enables clinicians to access real-time patient data and extend monitoring beyond traditional care models. We have seen success with the Corsano™* multi-parameter wearable across multiple use cases across Europe, including for use in stable patients in the emergency department, pre-operative care, medical surgical units, and cardiac care areas, with monitoring supporting patients along their care pathways, from pre-surgery to in-hospital recovery and into the home. We are excited to bring this innovative monitoring solution to the U.S. market," said Kate Benedict, president of the Acute Care and Monitoring business, which is part of the Medical Surgical Portfolio at Medtronic.

Corsano Health's CEO, Peter Stas, shared his enthusiasm for the partnership, stating, "At Corsano Health, our mission is to transform healthcare by giving clinicians actionable insights that can improve patient outcomes, from the hospital to the home. With this innovation, we envision advanced patient monitoring to be easier to use in daily clinical practice, which will help streamline workflows, support earlier intervention, and enable new ways of delivering care. Together, we are redefining connected care to meet the changing needs of health systems, help address workforce challenges, and support more personalized and efficient patient management at every stage of care."

This partnership underscores the growing role of medical-grade wearable monitoring in patient care today. As access to continuous data expands, clinical teams are able to make more informed decisions and uncover insights that were not previously visible. This reflects the commitment from Medtronic to pairing digital innovation with world-class medical devices. Learn more about the Corsano™* multi-parameter wearable from Medtronic here.

About Corsano Health
Corsano Health B.V. is a leading MedTech company that creates, manufactures, and sells advanced real-time remote patient monitoring solutions. With a CE-MDR medically certified system and FDA clearance, the Corsano™ multi-parameter wearable is setting new standards for continuous monitoring, focusing on our mission to lower healthcare costs and support clinical teams in improving outcomes and patient experiences. For more information, visit https://corsano.com/.

About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission - to alleviate pain, restore health, and extend life - unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visit www.Medtronic.com and follow on LinkedIn.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

* Third-party brands are trademarks of their respective owners
The Corsano™ multi-parameter wearable is manufactured by Corsano Health B.V and distributed by Medtronic.
The Corsano™ multi-parameter wearable should not be used as the sole basis for diagnosis or therapy and is intended only as an adjunct in patient assessment.

References

  1. Corsano™ multi-parameter wearable monitor IFU.

Contacts:
Pamela Lee
Public Relations
+1-303-218-8264

Ingrid Goldberg
Investor Relations
+1-763-505-2696

Medtronic plc published this content on June 04, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on June 04, 2026 at 13:20 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]